Pharmacological doses of all-trans retinoic acid promote G0/G1 transition and G1 arrest of normal human marrow CD34+ cells.
Herault
O
O
Gallay
N
N
Domenech
J
J
Colombat
P
P
Binet
C
C
D018952:Antigens, CD34 / Q000187:drug effects / Q000378:metabolism*; D001854:Bone Marrow Cells / Q000187:drug effects / Q000378:metabolism*; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D016193:G1 Phase / Q000187:drug effects* / Q000235:genetics; D005786:Gene Expression Regulation; D006801:Humans; D016192:Resting Phase, Cell Cycle / Q000187:drug effects* / Q000235:genetics; D014158:Transcription, Genetic / Q000187:drug effects; D014212:Tretinoin / Q000494:pharmacology*
D018952:Antigens, CD34; D014212:Tretinoin